We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.
- Authors
Schooley, Robert T; Spritzler, John; Wang, Hongying; Lederman, Michael M; Havlir, Diane; Kuritzkes, Daniel R; Pollard, Richard; Battaglia, Cathy; Robertson, Michael; Mehrotra, Devan; Casimiro, Danilo; Cox, Kara; Schock, Barbara; AIDS Clinical Trials Group 5197 Study Team
- Abstract
Human immunodeficiency virus type 1 (HIV-1)-specific cellular immunity contributes to the control of HIV-1 replication. HIV-1-infected volunteers who were receiving antiretroviral therapy were given a replication-defective adenovirus type 5 HIV-1 gag vaccine in a randomized, blinded therapeutic vaccination study.
- Publication
The Journal of infectious diseases, 2010, Vol 202, Issue 5, p705
- ISSN
1537-6613
- Publication type
Journal Article
- DOI
10.1086/655468